Note 6. Other Investments
FHLB and FRB Stock
The Company's investment in stock issued by the FHLB and FRB totaled $64.4 million and $90.0 million at December 31, 2013 and December 31, 2012, respectively. Ownership of government agency securities is restricted to member banks, and the securities do not have readily determinable market values. The Company records investments in FHLB and FRB stock at cost in Other assets of the consolidated balance sheets and evaluates these investments for impairment. The Company expects to recover the full amount invested in FHLB and FRB stock.
Private Equity and Alternative Investments
The Company has ownership interests in a limited number of private equity, venture capital, real estate and hedge funds that are not publicly traded and do not have readily determinable fair values. These investments are carried at cost in the Other assets section of the consolidated balance sheets and are net of impairment write-downs, if applicable. The Company's investments in these funds totaled $34.0 million at December 31, 2013 and $36.1 million at December 31, 2012. A summary of investments by fund type is provided below:
|
December 31, | ||||||
---|---|---|---|---|---|---|---|
(in thousands) Fund Type |
2013 | 2012 | |||||
Private equity and venture capital |
$ | 20,298 | $ | 20,693 | |||
Real estate |
7,646 | 9,223 | |||||
Hedge |
2,733 | 2,866 | |||||
Other |
3,275 | 3,309 | |||||
| | | | | | | |
Total |
$ | 33,952 | $ | 36,091 | |||
| | | | | | | |
| | | | | | | |
Management reviews these investments quarterly for impairment. The impairment assessment includes a review of the most recent financial statements and investment reports for each fund and discussions with fund management. An impairment loss is recognized if the Company does not expect to recover the cost of an investment. The impairment loss is recognized in Other noninterest income in the consolidated statements of income. The new cost basis of the investment is not adjusted for subsequent recoveries in value. The Company recognized impairment losses totaling $0.5 million, $3.3 million and $1.2 million on its other investments during 2013, 2012 and 2011, respectively.
The table below provides information as of December 31, 2013 on private equity and alternative investments measured at fair value on a nonrecurring basis due to the recognition of impairment:
(in thousands) Fund Type |
Fair Value |
Unfunded Commitments |
Redemption Frequency |
Redemption Notice Period | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Private equity and venture capital (1) |
$ | 662 | $ | 179 | None (2) | N/A | ||||
Hedge (3) |
233 | — | None (2) | N/A | ||||||
| | | | | | | | | | |
Total |
$ | 895 | $ | 179 | ||||||
| | | | | | | | | | |
| | | | | | | | | | |